3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.
Frequently asked questions
What sector does 3-D Matrix Ltd (DMTRF) operate in?
3-D Matrix Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.
What is 3-D Matrix Ltd (DMTRF) current stock price?
As of the latest data, 3-D Matrix Ltd stock price is $2.43, with a previous close of $2.43.
What is 3-D Matrix Ltd (DMTRF) current market capitalization?
3-D Matrix Ltd market cap is approximately 310.35 million.
What is 3-D Matrix Ltd (DMTRF) Earnings Per Share (EPS)?
The trailing EPS is $0.17.
What is 3-D Matrix Ltd (DMTRF) Price-to-Earnings (P/E) ratio?
3-D Matrix Ltd current P/E ratio is 14.26.
What is 3-D Matrix Ltd (DMTRF) EBITDA?
3-D Matrix Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 507.89 million.
Does 3-D Matrix Ltd (DMTRF) pay dividends?
No. 3-D Matrix Ltd does not pay a dividend.
What is 3-D Matrix Ltd (DMTRF) beta (volatility) score?
3-D Matrix Ltd has a beta of 0.988, meaning its volatility is roughly in line with the market.